Brasília — The Federal Official Gazette of Tuesday, September 16, published Ordinance No. 1.101 of September 15, 2025, issued by the National Health Surveillance Agency (Anvisa), appointing Mateus Amâncio Vitorino de Paulo as the new Executive Secretary of the Drug Market Regulation Chamber (CMED).

Mateus Amâncio Vitorino de Paulo holds a degree in Economics from the Institute of Economics of the Federal University of Rio de Janeiro (UFRJ), where he graduated with honors, and a master’s degree in Economic Theory from the University of São Paulo (USP). He has solid academic and professional experience in economic regulation, econometric simulations, and public policy impact analysis.

Throughout his career, he has worked as a researcher at the Central Bank of Brazil, in consulting firms, and in specialized research groups. He also completed an internship at the National Bank for Economic and Social Development (BNDES).

In his master’s dissertation, he analyzed the direct and distributive effects of regulatory changes in the Brazilian electricity sector, applying causal inference models and partial equilibrium analysis. During his academic training, he also worked as a teaching assistant in Microeconomics, Statistics, and Econometrics, in addition to publishing articles and presenting papers at national and international conferences.

Source: NK Consultores

Would you like a complete analysis on this? Contact us at pharmabrnews@gmail.com